相关实验视频

Updated: Mar 7, 2026

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

在AsCpf1中,异于目标的外核酶活动破坏了CRISPR诊断

Shixing Xue¹, He Sun², Xueyan Hou³

¹Department of Oncology and Hematology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130031, China.

Biosensors & bioelectronics

|March 5, 2026

概括

使用AsCpf1的CRISPR-Cas诊断显示出可变的敏感性,这是由于一种不具特征的外核酶活性降解DNA. 封装DNA3'末端解决了这一问题,显著提高了基于CRISPR的生物传感器性能.

科学领域:

分子生物学分子生物学
生物技术是生物技术.
生物化学生物化学

背景情况:

由于其可编程RNA引导的DNA裂变,CRISPR-Cas系统被广泛用于分子诊断.
基于AsCpf1的系统表现出无法解释的灵敏度变化,限制了它们的诊断效用.
了解底层机制对于优化CRISPR诊断工具至关重要.

研究的目的:

调查基于AsCpf1的诊断系统中无法解释的灵敏度变化的原因.
描述AsCpf1.1.的新型crRNA独立功能.
为提高CRISPR诊断的稳定性和准确性制定战略.

主要方法:

在AsCpf1.1.中检测外核酶活性的生物化学分析.
结构建模以预测新活动的本地化.
在CRISPR-EXPAR微RNA生物传感器的开发和测试.
3'终止限制策略的实施和验证.

主要成果:

在标准缓冲区 (Mg²⁺-依赖) 中,AsCpf1表现出显著的crRNA独立的外核酶活性.
这种外核酶活动与正规分裂不同,降解了目标DNA的自由3'端,降低了检测灵敏度.
结构建模表明该活动可能位于WED-PI域内.
3'端封顶有效地减轻了AsCpf1介导的降解,恢复了检测性能.
一个CRISPR-EXPAR微RNA生物传感器在3'端封闭后显示了~10倍的灵敏度改善.

结论:

AsCpf1具有以前未知的外核酶活性,这会干扰诊断应用.
这种外核酶活动通过降解DNA 3'端来损害目标识别.
3'端上限是克服这一局限性并增强基于CRISPR的诊断灵敏度和准确性的实用和有效策略.

关键词:

生物传感器是一种生物传感器.独立于crRNA的DNA分裂.这是一个微型RNA.分子对接是分子对接.空间可访问性空间可访问性这是一个WEDPI域名.

更多相关视频

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...